CNP and neoplasm: Circulating SIR markers, including the neutrophil–lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), or their combination (combined NLR and PLR: CNP) reflect the balance between pro-tumor inflammation associated with platelets and neutrophils and the anti-tumor immune response mediated by lymphocytes.